These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7274779)

  • 1. Automated estimation of factor Xa using the chromogenic substrate S-2222.
    Madaras F; Chew MY; Parkin JD
    Haemostasis; 1981; 10(5):271-5. PubMed ID: 7274779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated antithrombin III assay with a centrifugal analyser.
    Odegård OR; Rosenlund B; Ervik E
    Haemostasis; 1978; 7(4):202-9. PubMed ID: 658785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance control of oral anticoagulant therapy by an automated chromogenic substrate assay of factor X.
    Erskine JG; Walker ID; Davidson JF
    Clin Lab Haematol; 1982; 4(2):179-86. PubMed ID: 7116798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL
    Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Simultaneous determination of zymogen activation time and zymogen level using chromogenic substrates in blood coagulation analysis].
    Svendsen L; Brogli M; Stocker K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):150-6. PubMed ID: 6177596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin monitoring during cardiopulmonary bypass surgery using the one-step point-of-care whole blood anti-factor-Xa clotting assay heptest-POC-Hi.
    Hellstern P; Bach J; Simon M; Saggau W
    J Extra Corpor Technol; 2007 Jun; 39(2):81-6. PubMed ID: 17672188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD; Brandenburg VM; Lanzmich R; Floege J
    Nephrol Dial Transplant; 2004 Jun; 19(6):1552-8. PubMed ID: 15034159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated prothrombin-time test with use of a chromogenic peptide substrate and a centrifugal analyzer.
    Becker U; Jering H; Bartl K; Jilek F
    Clin Chem; 1984 Apr; 30(4):524-8. PubMed ID: 6705195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
    Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
    Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid determination of five coagulation parameters in one sample with a centrifugal analyzer.
    Bas BM; Costongs GM; Janson PC
    Haemostasis; 1987; 17(5):260-7. PubMed ID: 3478286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated determination of heparin with chromogenic substrates.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(2):184-94. PubMed ID: 6735276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assay of factor Xa on a centrifugal analyzer.
    Gram J; Jespersen J; Sidelmann J
    Thromb Res; 1984 Jan; 33(2):239-42. PubMed ID: 6367133
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of factor X and heparin with chromogenic substrate.
    Aiach M; Michaud A; Capron L; Fiessinger JN
    Acta Chir Scand Suppl; 1982; 509():109-13. PubMed ID: 6962612
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein C: a simplified semi-automated activity assay.
    Odegaard OR; Try K; Abildgaard U
    Thromb Res; 1986 Apr; 42(2):257-62. PubMed ID: 3754988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.